Two-fractionated stereotactic magnetic resonance-guided adaptive radiation therapy for patients with prostate cancer (SMART PRO trial): protocol for a confirmatory clinical trial.

Sadamoto ZendaTairo KashiharaTetsuo SaitoHiroyuki OkamotoNoriyuki KadoyaTakahiro ChibaShin-Ei NodaTakashi KawaguchiKeiichi JinguKeiko ShibuyaTakashi UnoHiroshi Igaki

Published in: BMJ open (2024)

UMIN000049746.

Keyphrases

clinical trial
magnetic resonance
prostate cancer
phase ii
phase iii
brain metastases
study protocol
randomized controlled trial
radical prostatectomy
open label
small cell lung cancer
double blind
anti inflammatory
contrast enhanced